Caveolin1: its roles in normal and cancer stem cells Xingning LaiYiling GuoLixia Xiong Review – Cancer Research 08 September 2021 Pages: 3459 - 3475
3D tumor angiogenesis models: recent advances and challenges Sharath M. BhatVaishnavi A. BadigerManjunath B. Joshi Review – Cancer Research Open access 06 October 2021 Pages: 3477 - 3494
Can axillary surgery be omitted in patients with breast pathologic complete response after neoadjuvant systemic therapy for breast cancer? A real-world retrospective study in China Rui ChenShuo LiXiaoming Zha Original Article – Cancer Research 16 August 2021 Pages: 3495 - 3501
Peritumoral edema status of glioblastoma identifies patients reaching long-term disease control with specific progression patterns after tumor resection and high-dose proton boost Hsiang-Kuang Tony LiangMasashi MizumotoHideyuki Sakurai Original Article – Cancer Research Open access 30 August 2021 Pages: 3503 - 3516
Validation of ZMYND8 as a new treatment target in hepatocellular carcinoma Sangjoon ChoiKeun-Woo LeeSang Yun Ha Original Article – Cancer Research 30 August 2021 Pages: 3517 - 3534
Interactions of occult tumor spread and surgical technique on overall and disease-free survival in patients operated for stage I and II right-sided colon cancer G. S. BanipalB. V. StimecThe RCC study group Original Article – Cancer Research Open access 24 August 2021 Pages: 3535 - 3543
Immune microenvironment composition in high-grade serous ovarian cancers based on BRCA mutational status Sara CorvignoJared K. BurksAnil K. Sood Original Article – Cancer Research 02 September 2021 Pages: 3545 - 3555
Five-year outcomes of stereotactic body radiation therapy (SBRT) for prostate cancer: the largest experience in China Xianzhi ZhaoYusheng YeHuojun Zhang Original Article – Cancer Research Open access 15 September 2021 Pages: 3557 - 3564
p53 is functionally inhibited in clear cell renal cell carcinoma (ccRCC): a mechanistic and correlative investigation into genetic and molecular characteristics Karoline DiesingSilvia RibbackNils Kroeger Original Article – Cancer Research Open access 09 September 2021 Pages: 3565 - 3576
Selective induction of rapid cytotoxic effect in glioblastoma cells by oscillating magnetic fields Santosh A. HelekarShashank HambardeMartyn A. Sharpe Original Article – Cancer Research 03 September 2021 Pages: 3577 - 3589
Blood lipids and risk of colon or rectal cancer: a Mendelian randomization study Xuexin LuoZhenxing TuJie Ding Original Article – Cancer Research 06 September 2021 Pages: 3591 - 3599
Metabolic active tumour volume quantified on [18F]FDG PET/CT further stratifies TNM stage IV non-small cell lung cancer patients Ana Luísa Gomes RochaMauro Alessandro Monteiro da ConceiçãoPaula Alexandra Amado Lapa Original Article – Cancer Research 27 September 2021 Pages: 3601 - 3611
The use of SBRT in the management of oligometastatic gynecological cancer: report of promising results in terms of tolerability and clinical outcomes Francesco CucciaEdoardo PastorelloFilippo Alongi Original Article – Cancer Research 20 September 2021 Pages: 3613 - 3618
Phase II trial of stereotactic body radiation therapy on adrenal gland metastases: evaluation of efficacy and impact on hormonal production Ciro FranzeseSara StefaniniMarta Scorsetti Original Article – Cancer Research 18 September 2021 Pages: 3619 - 3625
Investigation of the roles of IL-18 (-607 C/A) and IL-18 (-137 G/C) gene variations in bladder cancer development: case–control study Nevra AlkanliArzu AyGokhan Cevik Original Article – Cancer Research 22 September 2021 Pages: 3627 - 3637
Blocking antibody-mediated phosphatidylserine enhances cancer immunotherapy Jie ZhangZhujiang DaiDong Tang Review – Clinical Oncology 09 September 2021 Pages: 3639 - 3651
Drug resistance of targeted therapy for advanced non-small cell lung cancer harbored EGFR mutation: from mechanism analysis to clinical strategy Yuxin ZhaoHaiyong WangChengwei He Review – Clinical Oncology 18 October 2021 Pages: 3653 - 3664
Regorafenib versus cabozantinb as second-line treatment after sorafenib for unresectable hepatocellular carcinoma: matching-adjusted indirect comparison analysis Andrea Casadei-GardiniLorenza RimassaAlessandro Cucchetti Original Article – Clinical Oncology 20 March 2021 Pages: 3665 - 3671
Performance of initial LI-RADS 2018 treatment response in predicting survival of patients with hepatocellular carcinoma following TACE: a retrospective, single-center cohort study Krzysztof BartnikJoanna PodgórskaOlgierd Rowiński Original Article – Clinical Oncology Open access 28 March 2021 Pages: 3673 - 3683
Traits of cancer patients and CAM usage Sabine Andrea DufterJutta HübnerBijan Zomorodbakhsch Original Article – Clinical Oncology Open access 02 April 2021 Pages: 3685 - 3692
Economics influences therapy decisions in chronic myeloid leukaemia: should it? Qian JiangRichard A. LarsonRobert Peter Gale Original Article – Clinical Oncology 22 April 2021 Pages: 3693 - 3698
Prognostic impact of extranodal extension in patients with pN1–N2 lung adenocarcinoma Kotaro NomuraKeiju AokageGenichiro Ishii Original Article – Clinical Oncology 02 April 2021 Pages: 3699 - 3707
Comprehensive analysis of the clinicopathological features, targetable profile, and prognosis of mucinous adenocarcinoma of the lung Daisuke UedaMasaoki ItoMorihito Okada Original Article – Clinical Oncology 01 April 2021 Pages: 3709 - 3718
Ground glass opacity featured lung adenocarcinoma in teenagers Haoxuan WuYang ZhangHaiquan Chen Original Article – Clinical Oncology 07 April 2021 Pages: 3719 - 3724
Phase I clinical trial of EGFR-specific CAR-T cells generated by the piggyBac transposon system in advanced relapsed/refractory non-small cell lung cancer patients Yajun ZhangZhiwei ZhangQijun Qian Original Article – Clinical Oncology 25 May 2021 Pages: 3725 - 3734
The effect of adjuvant therapies on long-term outcome for primary resected synovial sarcoma in a series of mainly children and adolescents Monika ScheerChristian Vokuhlthe European Cooperative Weichteilsarkom Studiengruppe [CWS] Original Article – Clinical Oncology Open access 17 July 2021 Pages: 3735 - 3747
Significance of PD-L1 expression in the cytological samples of non-small cell lung cancer patients treated with immune checkpoint inhibitors Naofumi HaraEiki IchiharaKatsuyuki Kiura Original Article – Clinical Oncology 29 March 2021 Pages: 3749 - 3755
Using deep learning to predict microvascular invasion in hepatocellular carcinoma based on dynamic contrast-enhanced MRI combined with clinical parameters Danjun SongYueyue WangXiaoying Wang Original Article – Clinical Oncology 10 April 2021 Pages: 3757 - 3767
Crizotinib: aseptic abscesses in multiple organs during treatment of EML4-ALK-positive NSCLC Daniel WeberMiriam DeckerManfred P. Lutz Letter to the Editor Open access 09 August 2021 Pages: 3769 - 3771
Correction to: Knowledge transfer as a tool towards improvement of cancer care in low- and middle-income countries. 6th European Roundtable Meeting (ERTM), June 14th, 2019, Berlin, Germany O. OrtmannJ. TorodeFor the participants of the ERTM Correction Open access 02 July 2021 Pages: 3773 - 3773
